GI
ZYME icon

GAMMA Investing’s Zymeworks ZYME Stock Holding History

GAMMA Investing’s Portfolio ZYME Stock Details ZYME Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$29.1K Buy
1,114
+17
+2% +$432 ﹤0.01% 2632
2026
Q1 		$27.5K Buy
1,097
+112
+11% +$2.65K ﹤0.01% 2546
2025
Q4 		$25.9K Buy
985
+180
+22% +$3.93K ﹤0.01% 2470
2025
Q3 		$13.7K Sell
805
-5
-0.6% -$72 ﹤0.01% 2714
2025
Q2 		$10.2K Buy
810
+267
+49% +$3.18K ﹤0.01% 2796
2025
Q1 		$6.47K Buy
543
+10
+2% +$136 ﹤0.01% 2965
2024
Q4 		$7.8K Buy
533
+100
+23% +$1.4K ﹤0.01% 2731
2024
Q3 		$5.43K Buy
433
+321
+287% +$3.5K ﹤0.01% 2715
2024
Q2 		$953 Sell
112
-45
-29% -$401 ﹤0.01% 3068
2024
Q1 		$1.65K Buy
157
+100
+175% +$1.11K ﹤0.01% 2802
2023
Q4 		$618 Buy
+57
New +$454 ﹤0.01% 2916

Other funds holding ZYME

Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return
TE
Tema ETFs New York $3.09B AUM 72.72% 1-Year Est. Return
YIH
Y-Intercept (HK) Hong Kong $5.05B AUM 17.89% 1-Year Est. Return
PR
PSP Research Newtown Square, Pennsylvania $188M AUM
TWD
True Wealth Design Akron, Ohio $420M AUM 22.7% 1-Year Est. Return
VCM
Versant Capital Management Phoenix, Arizona $1.12B AUM 34.21% 1-Year Est. Return
FFA
Farther Finance Advisors San Francisco, California $12.8B AUM 26.53% 1-Year Est. Return

GAMMA Investing's ZYME Position: Q2 2026 in Review

GAMMA Investing increased its Zymeworks (ZYME) stake by 1.5% in Q2 2026, buying an estimated $432 and bringing the position to 1,114 shares worth $29.1K. The position accounts for ﹤0.01% of the portfolio, ranked #2632.

GAMMA Investing first reported a position in ZYME in Q4 2023 and has held it in 11 quarters since. 8 funds tracked by Wall St. Rank hold ZYME as of Q2 2026.

  • GAMMA Investing held 1,114 shares of Zymeworks worth $29.1K as of Q2 2026.
  • GAMMA Investing bought 17 Zymeworks shares in Q2 2026, an estimated $432.
  • Zymeworks made up ﹤0.01% of GAMMA Investing's portfolio in Q2 2026, its #2632 holding.
  • GAMMA Investing first reported a position in Zymeworks in Q4 2023 and has held it in 11 quarters since.
  • 8 funds tracked by Wall St. Rank held Zymeworks as of Q2 2026.

Based on GAMMA Investing's 13F filing for Q2 2026, filed 7 Jul 2026.